mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.003 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.004 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.004 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.004 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.005 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.005 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.007 |